tiprankstipranks
Cardiff Oncology, Inc. (DE:XE7C)
FRANKFURT:XE7C

Cardiff Oncology (XE7C) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Buy
12Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Cardiff Oncology, Inc.’s (XE7C) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Cardiff Oncology, Inc. is a Buy.
Cardiff Oncology, Inc.’s (XE7C) 20-Day exponential moving average is 1.52, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.562, making it a Buy.
Cardiff Oncology, Inc.’s (XE7C) 50-Day exponential moving average is 1.42, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.562, making it a Buy.

Cardiff Oncology (XE7C) Pivot Points

Feb 22, 2024, 02:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.56
1.56
1.56
1.56
1.56
1.56
1.56
Fibonacci
1.56
1.56
1.56
1.56
1.56
1.56
1.56
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cardiff Oncology (XE7C) Moving Averages

Feb 22, 2024, 02:35 AM
Period
Simple
Exponential
MA5
1.56Sell
1.56Sell
MA10
1.59Sell
1.56Sell
MA20
1.50Buy
1.52Buy
MA50
1.41Buy
1.42Buy
MA100
1.23Buy
1.36Buy
MA200
1.36Buy
1.40Buy
Cardiff Oncology, Inc.’s (XE7C) 10-Day exponential moving average is 1.56, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.562, making it a Sell.
Cardiff Oncology, Inc.’s (XE7C) 100-Day exponential moving average is 1.36, while Cardiff Oncology, Inc.’s (XE7C) share price is €1.562, making it a Buy.
Cardiff Oncology, Inc.’s (XE7C) stock price is €1.562 and Cardiff Oncology, Inc.’s (XE7C) 50-day simple moving average is 1.41, creating a Buy signal.
Cardiff Oncology, Inc.’s (XE7C) stock price is €1.562 and Cardiff Oncology, Inc.’s (XE7C) 100-day simple moving average is 1.23, creating a Buy signal.
Cardiff Oncology, Inc.’s (XE7C) stock price is €1.562 and Cardiff Oncology, Inc.’s (XE7C) 200-day simple moving average is 1.36, creating a Buy signal.

Cardiff Oncology (XE7C) Technical Indicators

Feb 22, 2024, 02:35 AM
Name
Value
Implied Action
RSI (14)
53.13
Neutral
STOCH (9,6)
25.49
Neutral
STOCHRSI (14)
59.00
Neutral
MACD (12,26)
0.05
Buy
ADX (14)
18.32
Buy
Williams %R
-47.13
Buy
CCI (14)
18.55
Neutral
ATR (14)
0.05
-
Ultimate Oscillator
41.84
Neutral
ROC
8.96
Buy
Cardiff Oncology, Inc.’s (XE7C) Relative Strength Index (RSI) is 53.13, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Trend Strength Indicator (ADX) is 18.32, creating a Buy signal.
Cardiff Oncology, Inc.’s (XE7C) Commodity Channel Index (CCI) is 18.55, creating a Neutral signal.
Cardiff Oncology, Inc.’s (XE7C) Price Rate of Change (ROC) is 8.96, creating a Buy signal.

FAQ

Is XE7C a Buy, Hold, or Sell?
Based on XE7C’s technical indicators, XE7C is a Buy.
    What is XE7C’s RSI (14)?
    XE7C’s RSI (14) is 53.13, which suggests XE7C is a Neutral.
      What is XE7C’s MACD?
      XE7C’s MACD is 0.05, which suggests XE7C is a Buy.
        What is XE7C’s 5-day moving average?
        XE7C’s 5-day moving average is 1.56, which suggests XE7C is a Sell.
          What is XE7C’s 20-day moving average?
          XE7C 20-day moving average is 1.50, which suggests XE7C is a Buy.
            What is XE7C’s 50-day moving average?
            XE7C’s 50-day moving average is 1.41, which suggests XE7C is a Buy.
              What is XE7C’s 200-day moving average?
              XE7C’s 200-day moving average is 1.36, which suggests XE7C is a Buy.
                What is XE7C’s Williams % R (14)?
                XE7C’s Williams % R (14) is -47.13, which suggests XE7C is a Buy.
                  What is XE7C’s CCI (14)?
                  XE7C’s CCI (14) is 18.55, which suggests XE7C is a Neutral.
                    What is the share price of Cardiff Oncology, Inc.?
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis